UGConsumer Defensive · Household & Personal ProductsTicker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 90 of 100 as at 12 Nov 2026 — among the strongest tenth.
Consensus tells you what everyone already believes. The model scores United-Guardian, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Volatility (96): The share price has been relatively steady.
Revisions (25): Analysts have, on balance, been cutting their forecasts.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on UG, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
UG appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and servers
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 12 Nov 2026, United-Guardian, Inc. returned +52.1% against +12.0% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 51% of US stocks
Cheaper than 37% of US stocks
Cheaper than 27% of US stocks
Cheaper than 63% of US stocks
Higher than 87% of US stocks
Higher than 92% of US stocks
Higher than 62% of US stocks
Higher than 86% of US stocks
Higher than 86% of US stocks
Higher than 79% of US stocks
Higher than 97% of US stocks
Higher than 95% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
United-Guardian, Inc. has a market value of $39.5M and an enterprise value of $0.0.
Revenue in the twelve months to 30 June 2026: $11.2M. The latest quarter grew 54.3% year on year.
Net income over the same four quarters: $2.5M, a 22.0% net margin.
Free cash flow in the twelve months to 30 June 2026: $3.4M.
United-Guardian, Inc. spent $2.3M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 12.6×.
Forward dividend yield: 6.90%, paying out 93% of earnings.
United-Guardian, Inc. employs 23 people — $487K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own United-Guardian, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
United-Guardian shares rallied after Q3 results, with revenue rising 54% year over year on strong pharmaceutical and cosmetic ingredient sales.
Why it matters — The reported sales growth and share rally are relevant to UG watchers tracking the company’s quarterly performance.
United-Guardian, Inc. announced its financial results for the third quarter and first nine months of 2026. The headline reports higher third-quarter earnings.
Why it matters — UG watchers may note the reported increase in third-quarter earnings alongside the company’s results announcement.
United-Guardian reported higher second-quarter sales and earnings per share, driven by strong growth in cosmetic ingredient sales and bolstered by other income.
Why it matters — UG watchers would view cosmetic ingredient growth as a key driver of the company's core business performance and profitability.
United-Guardian, Inc. reported its financial results for the second quarter and first half of 2026. Second-quarter net sales rose 10% to $3,108,267 with net income up 16% to $728,579, while six-month net sales rose 12% to $5,980,489 and net income increased 30% to $1,547,481.
Why it matters — The report shows year-over-year growth in both net sales and net income for the quarter and the first half of 2026, providing investors with an updated picture of the company's recent financial performance.
As at 12 Nov 2026, United-Guardian, Inc. ranks 90 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (96 of 100).
No analyst covering United-Guardian, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for UG are extrapolating price history, which says nothing about the business.
United-Guardian, Inc. returned +52.1% over the 12 months to 12 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
United-Guardian, Inc. is a specialty manufacturer focused on cosmetic ingredients, pharmaceutical products, medical lubricants, and sexual wellness ingredients.
The most recent item we track (Zacks Investment Research, 12 Nov 2026): "UG Stock Gains 28% After Q3 Earnings Surge Y/Y on Sales Growth". United-Guardian shares rallied after Q3 results, with revenue rising 54% year over year on strong pharmaceutical and cosmetic ingredient sales.
United-Guardian, Inc. is a specialty manufacturer focused on cosmetic ingredients, pharmaceutical products, medical lubricants, and sexual wellness ingredients. The company develops and markets formulations used in personal care, healthcare, and related industrial applications, with products designed to provide lubrication, texture, hydration, and sensory enhancement. Its portfolio includes hydrogel-based ingredients and finished products that support cosmetics, medical devices, and select prescription and antimicrobial uses. United-Guardian serves customers in the United States and international markets through a product mix centered on niche formulations and specialized applications. Headquartered in Hauppauge, New York, United-Guardian, Inc. operates as a research-driven supplier in the personal care and healthcare supply chain.
23 employees · United States · https://u-g.com
